General

Scientific breakthroughs at the Miami Dupuytren Symposium
By: Charles Eaton
Aug 8, 2010

It’s been a few months since the 2010 International Symposium on Dupuytren’s Disease in Miami, FL. This was a huge undertaking – the the first meeting of this scope and magnitude in 20 years, and some incredible new developments were showcased. There was so much material presented it’s taking a while to sort through things, […]

Read more ›
Miami International Dupuytren Symposium Breaks New Ground
On: May 19, 2010
By: Charles Eaton

Medical researchers and physicians from 15 countries converge May 22 and 23 at the Intercontinental Hotel in Miami for an intensive two day summit on Dupuytren’s Disease: www.DupuytrenSymposium.com. Dupuytren’s disease is a progressive condition which gradually curls the fingers permanently into the palm. It is estimated that 3 to 9 million Americans have bent fingers […]

Read more ›
A personal look at Dupuytren’s
On: Mar 10, 2010
By: Charles Eaton

A family physician remembers his late father’s Dupuytren’s and muses on options for treatment: http://www.greatfallstribune.com/article/20100309/LIFESTYLE/3090307/Hands+become+claws+in+victims+of+Dupuytren+s. The observation “…in his final years he was wearied by the thought of ‘another procedure’ or treatment and decided to live with the condition” is a telling testimony for the need for better treatment options and the need to support […]

Read more ›
Reimbursement for Needle Aponeurotomy and for Xiaflex
On: Feb 24, 2010
By: Charles Eaton

Needle aponeurotomy (NA) is referred to as percutaneous fasciotomy in the AMA Common Procedural Terminology (CPT) listing. CPT codes are the standard language used by health care providers and the insurance industry regarding reimbursement. Several years ago, Blue Cross of Massachusetts quietly removed the code for NA (26040) from their list of reimbursed procedures, as […]

Read more ›
Botox and Dupuytren’s
On: Jan 24, 2010
By: Charles Eaton

The holy grail of treating Dupuytren’s contracture is “disease modification”: how to stop progression or recurrence in a safe, nontoxic way? Three articles hint at the tantalizing possibility of the use of Botox (botulinum toxin) for Dupuytren’s. Botox includes two classes of enzymes which affect two different biologic systems. The first enzyme, which made Botox […]

Read more ›
Dupuytren’s Review
On: Jan 5, 2010
By: Charles Eaton

Despite being a visible, obvious problem, Dupuytren’s is difficult to understand, like the Jimmy Buffet line “so simple – like the jitterbug – it plumb evaded me”. It is helpful to review the basics on a regular basis to keep a clear perspective. Here is a great review for hand surgeons and non hand surgeons […]

Read more ›
Fifty years of Dupuytren’s Patients Reviewed
On: Jan 1, 2010
By: Charles Eaton

One of the more puzzling things about Dupuytren’s is the variation in demographic data. Taking away the variation in results from different surgeons doing different operations, one would expect a standard pattern of who is at risk, what conditions are associated. Not so. A review of nearly 3000 Dupuytren patients seen over 50 years at […]

Read more ›
Tissue markers for Dupuytren’s
On: Dec 27, 2009
By: Charles Eaton

Is it possible to predict the course of Dupuytren’s in an individual? Who will need surgery? Who will have rapid progression or an early recurrence after surgery and who won’t? Family and personal history provide general trends, but that’s all. Several studies have correlated the cellularity of nodule tissue and the presence of myofibroblasts with […]

Read more ›